Impact Factor Current: 3.428
5 - Year: 3.146

Current Cancer Drug Targets

ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Latest Issue: Volume 21 , Issue 8 , 2021

Back Journal Home
Impact Factor
Web of Science Impact Factor

Current: 3.428
5 - Year: 3.146

Ranking & Category

  • ONCOLOGY 140th of 222

Topics Covered

1 Topics

View
Covered Diseases

1 Diseases

View

Aims & Scope

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters, reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Abstracted/Indexed in


BIOBASE, Biochemistry & Biophysics Citation Index®, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Biotechnology Citation Index®, British Library, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE, ERA 2018, Genamics JournalSeek, Google Scholar, InCites, Index Copernicus, Index to Scientific Reviews®, ISI Alerting Service, J-Gate, Journal Citation Reports/Science Edition, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed/Index Medicus, Norwegian Register, Prous Science Integrity, PubsHub, QOAM, Science Citation Index Expanded™ (SciSearch®), Scilit, Scopus, Suweco CZ, TOC Premier, and Ulrich's Periodicals Directory

Special Offers

Abstracted/Indexed in
COPE COMPLIANT
Endorsement(s)

"In view of the growing volume of literature, the role of high quality review journals has become increasingly important. Current Drug Targets is an important journal in the field of medicinal chemistry and drug design, which is strongly recommended to the scientific community."

Jean-Marie Lehn
Nobel Laureate

Forthcoming Special Issue(s)

Nanotechnology Based Theranostic Approaches Against Cancerous Malignancies and Infectious Diseases
Guest Editor(s): Shahper Nazeer Khan, Octavio Luiz Franco, Absar Ahmad

Submit Abstract via Email

Download Description

Published Special Issue(s)
Authors' Comments

It was a nice experience to publish our article in current drug target. I felt that the journal is quick and has maintained very high standard by independently reviewing article from more than five reviewers. The communication between the author and the Journals editorial is also speedy. I hope the journal will continue to maintain and sustain its reputation. 

Pushpender K. Sharma
(Department of Biotechnology, Sri Guru Granth Sahib World University, Fatehgarh Sahib, Pb, India.)

© 2021 Bentham Science Publishers | Privacy Policy